These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 12575813)

  • 1. Splenectomy for children with thalassemia.
    Al-Salem AH; Nasserulla Z
    Int Surg; 2002; 87(4):269-73. PubMed ID: 12575813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of partial splenectomy in children with thalassemia.
    al-Salem AH; al-Dabbous I; Bhamidibati P
    Eur J Pediatr Surg; 1998 Dec; 8(6):334-8. PubMed ID: 9926300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenectomy for Children With Thalassemia: Total or Partial Splenectomy, Open or Laparoscopic Splenectomy.
    Al-Salem AH
    J Pediatr Hematol Oncol; 2016 Jan; 38(1):1-4. PubMed ID: 24577545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of the splenectomy in children with thalassemia.
    Hathirat P; Isarangkura P; Numhom S; Opasathien P; Chuansumrit A
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():133-8. PubMed ID: 2732635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications and complications of splenectomy for children with sickle cell disease.
    Al-Salem AH
    J Pediatr Surg; 2006 Nov; 41(11):1909-15. PubMed ID: 17101369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Blood Disorders Survey in the Sultanate of Oman.
    Al-Riyami A; Ebrahim GJ
    J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Partial splenectomy in thalassemia major. Apropos of 19 cases].
    Kehila M; Khelif A; Kharrat H; Ennabli S; Abderrahim T
    J Chir (Paris); 1994 Feb; 131(2):99-103. PubMed ID: 8207104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial splenectomy in the treatment of thalassaemia major.
    Kheradpir MH; Alebouyeh M
    Z Kinderchir; 1985 Aug; 40(4):195-8. PubMed ID: 4060888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenectomy for haematological disorders: a single center study in 150 patients from Oman.
    Machado NO; Grant CS; Alkindi S; Daar S; Al-Kindy N; Al Lamki Z; Ganguly SS
    Int J Surg; 2009 Oct; 7(5):476-81. PubMed ID: 19695352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transfusion requirements and mean annual hemoglobin level in thalassemia major].
    Brunengo MA; Girot R
    Nouv Rev Fr Hematol (1978); 1986; 28(5):309-13. PubMed ID: 3808940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial splenectomy prevents splenic sequestration crises in sickle cell disease.
    Vick LR; Gosche JR; Islam S
    J Pediatr Surg; 2009 Nov; 44(11):2088-91. PubMed ID: 19944213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications and results for splenectomy for beta thalassemia in two hundred and twenty-one pediatric patients.
    Pinna AD; Argiolu F; Marongiu L; Pinna DC
    Surg Gynecol Obstet; 1988 Aug; 167(2):109-13. PubMed ID: 3400027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
    Corapcioglu F; Aksu G; Basar EZ; Demirel A; Oncel S; Mutlu A
    Pediatr Hematol Oncol; 2008 Sep; 25(6):509-21. PubMed ID: 18728970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia.
    Bradai M; Pissard S; Abad MT; Dechartres A; Ribeil JA; Landais P; de Montalembert M
    Transfusion; 2007 Oct; 47(10):1830-6. PubMed ID: 17880608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyurea in the treatment of major beta-thalassemia and importance of genetic screening.
    Alebouyeh M; Moussavi F; Haddad-Deylami H; Vossough P
    Ann Hematol; 2004 Jul; 83(7):430-3. PubMed ID: 14722738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is splenectomy for massive splenomegaly safe in children?
    Al-Salem AH
    Am J Surg; 1999 Jul; 178(1):42-5. PubMed ID: 10456701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenectomy reduces packed red cell transfusion requirement in children with sickle cell disease.
    Haricharan RN; Roberts JM; Morgan TL; Aprahamian CJ; Hardin WD; Hilliard LM; Georgeson KE; Barnhart DC
    J Pediatr Surg; 2008 Jun; 43(6):1052-6. PubMed ID: 18558181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High transfusion in children with beta-thalassemia/Hb E: clinical and laboratory assessment of 18 cases.
    Torcharus K; Withayathawornwong W; Sriphaisal T; Krutvacho T; Arnutti P; Suwanasophorn C
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():96-9. PubMed ID: 7886617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenectomy after paediatric trauma: could more spleens be saved?
    Godbole P; Stringer MD
    Ann R Coll Surg Engl; 2002 Mar; 84(2):106-8. PubMed ID: 11995746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.